These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31784646)

  • 1. Non-SMC condensin I complex subunit H mediates mature chromosome condensation and DNA damage in pancreatic cancer cells.
    Kim JH; Youn Y; Kim KT; Jang G; Hwang JH
    Sci Rep; 2019 Nov; 9(1):17889. PubMed ID: 31784646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NCAPH Is Required for Proliferation, Migration and Invasion of Non-small-cell Lung Cancer Cells.
    Kim B; Kim SW; Lim JY; Park SJ
    Anticancer Res; 2020 Jun; 40(6):3239-3246. PubMed ID: 32487618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NCAPH plays important roles in human colon cancer.
    Yin L; Jiang LP; Shen QS; Xiong QX; Zhuo X; Zhang LL; Yu HJ; Guo X; Luo Y; Dong J; Kong QP; Yang CP; Chen YB
    Cell Death Dis; 2017 Mar; 8(3):e2680. PubMed ID: 28300828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NCAPH Stabilizes GEN1 in Chromatin to Resolve Ultra-Fine DNA Bridges and Maintain Chromosome Stability.
    Kim JH; Youn Y; Hwang JH
    Mol Cells; 2022 Nov; 45(11):792-805. PubMed ID: 36380731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NCAPH regulates gastric cancer progression through DNA damage response.
    Wang Y; Li JQ; Yang ZL; Wang L; Zhang JC; Sun YF; Li ZY; Qin L
    Neoplasma; 2022 Mar; 69(2):283-291. PubMed ID: 34962823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-SMC condensin I complex subunit H enhances proliferation, migration, and invasion of hepatocellular carcinoma.
    Sun C; Huang S; Wang H; Xie R; Zhang L; Zhou Q; He X; Ju W
    Mol Carcinog; 2019 Dec; 58(12):2266-2275. PubMed ID: 31523845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of MYBL2 promotes proliferation and migration of non-small-cell lung cancer via upregulating NCAPH.
    Xiong YC; Wang J; Cheng Y; Zhang XY; Ye XQ
    Mol Cell Biochem; 2020 May; 468(1-2):185-193. PubMed ID: 32200471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OCT1 Is a Poor Prognostic Factor for Breast Cancer Patients and Promotes Cell Proliferation via Inducing NCAPH.
    Ogura T; Azuma K; Sato J; Kinowaki K; Takayama KI; Takeiwa T; Kawabata H; Inoue S
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NCAPH promotes cell proliferation and inhibits cell apoptosis of bladder cancer cells through MEK/ERK signaling pathway.
    Li B; Xiao Q; Shan L; Song Y
    Cell Cycle; 2022 Feb; 21(4):427-438. PubMed ID: 34974790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NCAPH is upregulated in endometrial cancer and associated with poor clinicopathologic characteristics.
    Qiu X; Gao Z; Shao J; Li H
    Ann Hum Genet; 2020 Nov; 84(6):437-446. PubMed ID: 32628282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NCAPH is a prognostic biomarker and associated with immune infiltrates in lung adenocarcinoma.
    Li C; Meng J; Zhang T
    Sci Rep; 2022 Jun; 12(1):9578. PubMed ID: 35688915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of NCAPH in cancer treatment.
    Liu C; Han X; Zhang S; Huang M; Guo B; Zhao Z; Yang S; Jin J; Pu W; Yu H
    Cell Signal; 2024 Sep; 121():111262. PubMed ID: 38901722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Condensin recruitment to chromatin is inhibited by Chk2 kinase in response to DNA damage.
    Zhang T; Si-Hoe SL; Hudson DF; Surana U
    Cell Cycle; 2016 Dec; 15(24):3454-3470. PubMed ID: 27792460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-SMC condensin I complex subunit H promotes the malignant progression and cisplatin resistance of breast cancer MCF-7 cells.
    Liao L; Cheng H; Liu S
    Oncol Lett; 2022 Sep; 24(3):317. PubMed ID: 35949592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NCAPH is negatively associated with Mcl‑1 in non‑small cell lung cancer.
    Xiong Q; Fan S; Duan L; Liu B; Jiang X; Chen X; Xiong C; Tao Q; Wang J; Zhang H; Chen C; Duan Y
    Mol Med Rep; 2020 Oct; 22(4):2916-2924. PubMed ID: 32945371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of NCAPH is upregulated and predicts a poor prognosis in prostate cancer.
    Cui F; Hu J; Xu Z; Tan J; Tang H
    Oncol Lett; 2019 Jun; 17(6):5768-5776. PubMed ID: 31186803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of Chk1 sensitizes human colon carcinoma HCT116 cells in a p53-dependent manner to lidamycin through abrogation of a G2/M checkpoint and induction of apoptosis.
    Pan Y; Ren KH; He HW; Shao RG
    Cancer Biol Ther; 2009 Aug; 8(16):1559-66. PubMed ID: 19502782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of hCAP-D2, a non-SMC subunit of condensin I, to chromosome and chromosomal protein dynamics during mitosis.
    Watrin E; Legagneux V
    Mol Cell Biol; 2005 Jan; 25(2):740-50. PubMed ID: 15632074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of NCAPH as a biomarker for prognosis of breast cancer.
    Lu H; Shi C; Wang S; Yang C; Wan X; Luo Y; Tian L; Li L
    Mol Biol Rep; 2020 Oct; 47(10):7831-7842. PubMed ID: 33009967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micro-ribonucleic acid expression signature of metastatic castration-resistant prostate cancer: Regulation of NCAPH by antitumor miR-199a/b-3p.
    Arai T; Kojima S; Yamada Y; Sugawara S; Kato M; Yamazaki K; Naya Y; Ichikawa T; Seki N
    Int J Urol; 2019 Apr; 26(4):506-520. PubMed ID: 30818424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.